Evidence map›Paper›PMID 23617307›Full record

ArticleBMC medical genetics2013

Genetic variants of MARCO are associated with susceptibility to pulmonary tuberculosis in a Gambian population.

Dawn Me Bowdish, Kaori Sakamoto, Nathan A Lack, Philip C Hill, Giorgio Sirugo, Melanie J Newport, Siamon Gordon, Adrian Vs Hill, Fredrick O Vannberg

Open access · goldAbstract read
In one paragraph

Article in BMC medical genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Journal of medical microbiology · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. MARCOThe EMBO journal · 2021
    Article
  7. eLife · 2021
    Article
  8. Review
  9. Article
  10. Article
  11. THE EXPOSOME IN HUMAN EVOLUTION: FROM DUST TO DIESEL.The Quarterly review of biology · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 9 institutions in 7 countries.

Dawn Me BowdishMcMaster Immunology Research Centre, McMaster University, Hamilton, ON, L8S 4K1, Canada. bowdish@mcmaster.ca
Kaori Sakamoto
Nathan A Lack
Philip C Hill
Giorgio Sirugo
Melanie J Newport
Siamon Gordon
Adrian Vs Hill
Fredrick O Vannberg
Brighton and Sussex Medical School · GBCentre for Human Genetics · GBGeorgia Institute of Technology · USKoç University · TRMcMaster University · CAMRC Unit the Gambia · GMOspedale San Pietro Fatebenefratelli · ITUniversity of Georgia · USUniversity of Oxford · GB

Funding

Role of MARCO in susceptibility and resistance to tuberculosisR15AI094436 · NIAID · UNIVERSITY OF GEORGIA · PI SAKAMOTO, KAORI · 2012 to 2012
$405k
NIAID NIH HHS 1 R15 AI094436-01A1NIAID NIH HHS R15 AI094436Wellcome Trust 090532
6 · The paper itself

Abstract

backgroundThe two major class A scavenger receptors are scavenger receptor A (SRA), which is constitutively expressed on most macrophage populations, and macrophage receptor with collagenous structure (MARCO), which is constitutively expressed on a more restricted subset of macrophages, (e.g. alveolar macrophages) but whose expression increases on most macrophages during the course of infection. Although the primary role of SRA appears to be clearance of modified host proteins and lipids, mice defective in expression of either MARCO or SRA are immunocompromised in multiple models of infection and in vitro assays, the scavenger receptors have been demonstrated to bind bacteria and to enhance pro-inflammatory signalling to many bacterial lung pathogens; however their importance in Mycobacterium tuberculosis infection, is less clear.

methodsTo determine whether polymorphisms in either SRA or MARCO were associated with tuberculosis, a case-control study of was performed. DNA samples from newly-detected, smear-positive, pulmonary tuberculosis cases were collected from The Gambia. Controls for this study consisted of DNA from cord bloods obtained from routine births at local Gambian health clinics. Informed written consent was obtained from patients or their parents or guardians. Ethical approval was provided by the joint The Gambian Government/MRC Joint Ethics Committee.

resultsWe studied the frequencies of 25 polymorphisms of MSR1 (SRA) and 22 in MARCO in individuals with tuberculosis (n=1284) and matched controls (n=1349). No SNPs within the gene encoding or within 1 kb of the promoter sequence of MSR1 were associated with either susceptibility or resistance to tuberculosis. Three SNPs in MARCO (rs4491733, Mantel-Haenszel 2x2 χ2 = 6.5, p = 0.001, rs12998782, Mantel-Haenszel 2x2 χ2 = 6.59, p = 0.001, rs13389814 Mantel-Haenszel 2x2 χ2 = 6.9, p = 0.0009) were associated with susceptibility to tuberculosis and one (rs7559955, Mantel-Haenszel 2x2 χ2 = 6.9, p = 0.0009) was associated with resistance to tuberculosis.

conclusionsThese findings identify MARCO as a potentially important receptor in the host response to tuberculosis.

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideCase-Control StudiesComputational BiologyDNAFemaleGambiaGene FrequencyHeterozygoteHumansIntronsLogistic ModelsMacrophagesMalePromoter Regions, GeneticReceptors, ImmunologicDNAMARCO protein, humanMSR1 protein, humanReceptors, ImmunologicScavenger Receptors, Class A

Identifiers

PMID23617307
PMCPMC3652798
OpenAlexW2072594666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.